Case number 1:23-cv-00424
Celgene Corporation et al v. Accord Healthcare Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Nov 27, 2023 | 9 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 11,571,436 B2. (Attachments: # 1 Order)(nms) (Entered: 11/27/2023) (0) |
| May 1, 2023 | 7 | STIPULATION and [Proposed] Order to Consolidate and Modify Scheduling Order by Bristol-Myers Squibb Company, Celgene Corporation, Celgene International Sarl, Celgene International Sarl. (Attachments: # 1 Exhibit A)(Farnan, Brian) (Entered: 05/01/2023) (Main Document) (3) |
| May 1, 2023 | 8 | SO ORDERED Granting (D.I. 7 in 23-cv-424-RGA; D.I. 43 in 21-cv-1795-RGA) Stipulation and Proposed Order to Consolidate and Modify Scheduling Order (*Reset Deadlines/Hearings: Fact Discovery completed by 8/30/2023; 3 day Bench Trial is now set to start 5/20/2024, at 8:30 AM in Courtroom 6A; A Pretrial Conference is set for 5/10/2024, at 9:00 AM in Courtroom 6A (see Order for further details). Signed by Judge Richard G. Andrews on 5/1/2023. Associated Cases: 1:21-cv-01795-RGA, 1:23-cv-00424-RGA(nms) (Entered: 05/01/2023) (5) |
| May 1, 2023 | 7 | STIPULATION and [Proposed] Order to Consolidate and Modify Scheduling Order by Bristol-Myers Squibb Company, Celgene Corporation, Celgene International Sarl, Celgene International Sarl. (Attachments: # 1 Exhibit A)(Farnan, Brian) (Entered: 05/01/2023) (Exhibit A) (2) |
| Apr 26, 2023 | N/A | Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) (Entered: 04/26/2023) (0) |
| Apr 18, 2023 | 1 | COMPLAINT for PATENT INFRINGEMENT filed against Accord Healthcare Inc. (Filing fee $ 402, receipt number ADEDC-4115858.) - filed by Celgene Corporation, Bristol-Myers Squibb Company, and Celgene International Sarl. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet) (mkr) (Entered: 04/18/2023) (Main Document) (9) |
| Apr 18, 2023 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mkr) (Entered: 04/18/2023) (3) |
| Apr 18, 2023 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: March 16, 2023. Date of Expiration of Patent: May 15, 2029. (mkr) (Entered: 04/18/2023) (2) |
| Apr 18, 2023 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 11,571,436 B2. (mkr) (Entered: 04/18/2023) (1) |
| Apr 18, 2023 | 5 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Bristol-Myers Squibb Company for Celgene Corporation; Corporate Parent Celgene Corporation for Celgene International Sarl filed by Bristol-Myers Squibb Company, Celgene Corporation, Celgene International Sarl. (mkr). (Entered: 04/18/2023) (2) |
| Apr 18, 2023 | 6 | Summons Issued as to Accord Healthcare Inc. on 4/18/2023. (Entered: 04/18/2023) (2) |
| Apr 18, 2023 | 1 | COMPLAINT for PATENT INFRINGEMENT filed against Accord Healthcare Inc. (Filing fee $ 402, receipt number ADEDC-4115858.) - filed by Celgene Corporation, Bristol-Myers Squibb Company, and Celgene International Sarl. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet) (mkr) (Entered: 04/18/2023) (Exhibit A) (30) |
| Apr 18, 2023 | 1 | COMPLAINT for PATENT INFRINGEMENT filed against Accord Healthcare Inc. (Filing fee $ 402, receipt number ADEDC-4115858.) - filed by Celgene Corporation, Bristol-Myers Squibb Company, and Celgene International Sarl. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet) (mkr) (Entered: 04/18/2023) (Exhibit B) (30) |
| Apr 18, 2023 | 1 | COMPLAINT for PATENT INFRINGEMENT filed against Accord Healthcare Inc. (Filing fee $ 402, receipt number ADEDC-4115858.) - filed by Celgene Corporation, Bristol-Myers Squibb Company, and Celgene International Sarl. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet) (mkr) (Entered: 04/18/2023) (Civil Cover Sheet) (1) |
